-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IvgjbPM/kpSlXBBQG4UHjbpBtBOYkjtvc1403qjzM1hwFNFo5JGDbIh/sIYDQy2+ jmfCrBz2tsyK/+vxrFxVig== 0001209191-10-044850.txt : 20100902 0001209191-10-044850.hdr.sgml : 20100902 20100902143801 ACCESSION NUMBER: 0001209191-10-044850 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100901 FILED AS OF DATE: 20100902 DATE AS OF CHANGE: 20100902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Labinger Barry CENTRAL INDEX KEY: 0001332456 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14169 FILM NUMBER: 101054688 MAIL ADDRESS: STREET 1: 6791 BRENDAN COURT CITY: EDINA STATE: MN ZIP: 55439 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMAN GENOME SCIENCES INC CENTRAL INDEX KEY: 0000901219 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 223178468 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850-3338 BUSINESS PHONE: 3013098504 MAIL ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2010-09-01 0 0000901219 HUMAN GENOME SCIENCES INC HGSI 0001332456 Labinger Barry 14200 SHADY GROVE ROAD ROCKVILLE MD 20850 0 1 0 0 Exec VP & CCO Common Stock 2010-09-01 4 M 0 50000 4.92 A 50000 D Common Stock 2010-09-01 4 S 0 50000 30.0156 D 0 D Employee stock option right to buy 4.92 2010-09-01 4 M 0 50000 0.00 D 2018-03-10 Common Stock 50000 70871 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective 6/16/10. This transaction was executed in multiple trades at prices ranging from $30.00 to $30.06. The price reported above reflects the weighted average sales price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available. One-eighth of the 150,000 options granted on March 10, 2008, vested on the six-month anniversary date (September, 2008) and the remaining options granted vested and continue to vest monthly on a ratable basis for the next 42 months commencing on October 10, 2008. /s/ Barry A. Labinger 2010-09-02 -----END PRIVACY-ENHANCED MESSAGE-----